Other Species / Isoforms
  NMD3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S11-p
MAESTDRsPGHILCC
0 3
NMD3 (human) MAESTDRsPGHILCC S11-p
NMD3 (mouse) MAESIEHSPGHILCC S11
NMD3 (rat) MTESVDRSPGHILCC S11
S25-p
CECGVPIsPNPANIC
0 6
NMD3 (human) CECGVPIsPNPANIC S25-p
NMD3 (mouse) CECGVPISPNPANIC S25
NMD3 (rat) CECGVPISPNPANIC S25
K39-ub
CVACLRSkVDISQGI
0 1
NMD3 (human) CVACLRSkVDISQGI K39-ub
NMD3 (mouse) CVACLRSKVDISQGV K39
NMD3 (rat) CVACLRSKVDISQGV K39
S51-p
QGIPKQVsISFCKQC
0 1
NMD3 (human) QGIPKQVsISFCKQC S51-p
NMD3 (mouse) QGVPKQVSISFCKQC S51
NMD3 (rat) QGVPKQVSISFCKQC S51
K84-ub
ELLALCLkkIKAPLS
0 1
NMD3 (human) ELLALCLkkIKAPLS K84-ub
NMD3 (mouse) ELLALCLKKIKAPLS K84
NMD3 (rat) ELLALCLKKIKAPLS K84
K85-ac
LLALCLkkIKAPLSK
0 1
NMD3 (human) LLALCLkkIKAPLSK K85-ac
NMD3 (mouse) LLALCLKKIKAPLSK K85
NMD3 (rat) LLALCLKKIKAPLSK K85
K108-ub
VWTEPHSkRLKVKLT
0 1
NMD3 (human) VWTEPHSkRLKVKLT K108-ub
NMD3 (mouse) VWTEPHSKRLKVKLT K108
NMD3 (rat) VWTEPHSKRLKVKLT K108
K150-ub
DCHRVEAkDFWKAVI
Upstream
0 2
Treatment
  • MG132
NMD3 (human) DCHRVEAkDFWKAVI K150-ub
NMD3 (mouse) DCHRVEAKDFWKAVI K150
NMD3 (rat) DCHRVEAKDFWKAVI K150
Y179
LEQLILKYGMHQNTL
0 1
NMD3 (human) LEQLILKYGMHQNTL Y179
NMD3 (mouse) LEQLILKyGMHQNTL Y179-p
NMD3 (rat) LEQLILKYGMHQNTL Y179
K202-ub
LDFYYSSkQHAQKMV
0 1
NMD3 (human) LDFYYSSkQHAQKMV K202-ub
NMD3 (mouse) LDFYYSSKQHAQKMV K202
NMD3 (rat) LDFYYSSKQHAQKMV K202
T235-p
SQDIHSNtyNyKSTF
0 3
NMD3 (human) SQDIHSNtyNyKSTF T235-p
NMD3 (mouse) SQDIHSNTyNYKSTF T235
NMD3 (rat) SQDIHSNTYNYKSTF T235
Y236-p
QDIHSNtyNyKSTFS
Upstream
0 36
Treatment
  • FGF2
  • HGF
NMD3 (human) QDIHSNtyNyKSTFS Y236-p
NMD3 (mouse) QDIHSNTyNYKSTFS Y236-p
NMD3 (rat) QDIHSNTYNYKSTFS Y236
Y238-p
IHSNtyNyKSTFSVE
0 35
NMD3 (human) IHSNtyNyKSTFSVE Y238-p
NMD3 (mouse) IHSNTyNYKSTFSVE Y238
NMD3 (rat) IHSNTYNYKSTFSVE Y238
S258-p
KDNVVCLsPKLAQSL
0 7
NMD3 (human) KDNVVCLsPKLAQSL S258-p
NMD3 (mouse) KDNVVCLsPKLAQSL S258-p
NMD3 (rat) KDNVVCLSPKLAQSL S258
S337-p
AAGAGMIskkHTLGE
0 1
NMD3 (human) AAGAGMIskkHTLGE S337-p
NMD3 (mouse) SAGAGVISKKHTLGE S337
NMD3 (rat) NAGAGVISKKHTLGE S337
K338-ac
AGAGMIskkHTLGEV
0 1
NMD3 (human) AGAGMIskkHTLGEV K338-ac
NMD3 (mouse) AGAGVISKKHTLGEV K338
NMD3 (rat) AGAGVISKKHTLGEV K338
K339-ub
GAGMIskkHTLGEVW
0 1
NMD3 (human) GAGMIskkHTLGEVW K339-ub
NMD3 (mouse) GAGVISKKHTLGEVW K339
NMD3 (rat) GAGVISKKHTLGEVW K339
K349-ub
LGEVWVQkTSEMNTD
0 1
NMD3 (human) LGEVWVQkTSEMNTD K349-ub
NMD3 (mouse) LGEVWIQKTSEMNTD K349
NMD3 (rat) LGEVWIQKTSEMDTD K349
K357-ub
TSEMNTDkQYFCRTH
0 3
NMD3 (human) TSEMNTDkQYFCRTH K357-ub
NMD3 (mouse) TSEMNTDKQYFCRTH K357
NMD3 (rat) TSEMDTDKQYFCRTH K357
S395-p
EHVNKMNsDrVPDVV
0 1
NMD3 (human) EHVNKMNsDrVPDVV S395-p
NMD3 (mouse) EYVNKMNSDRVPDVV S395
NMD3 (rat) EHVNKMKSDRVPDVV S395
R397-m1
VNKMNsDrVPDVVLI
0 1
NMD3 (human) VNKMNsDrVPDVVLI R397-m1
NMD3 (mouse) VNKMNSDRVPDVVLI R397
NMD3 (rat) VNKMKSDRVPDVVLI R397
T433-p
RERENMDtDDErQyQ
0 17
NMD3 (human) RERENMDtDDErQyQ T433-p
NMD3 (mouse) RDRENMDtDDERQYQ T433-p
NMD3 (rat) RDREDMDtDDERQYQ T433-p
R437-m1
NMDtDDErQyQDFLE
0 1
NMD3 (human) NMDtDDErQyQDFLE R437-m1
NMD3 (mouse) NMDtDDERQYQDFLE R437
NMD3 (rat) DMDtDDERQYQDFLE R437
Y439-p
DtDDErQyQDFLEDL
0 2
NMD3 (human) DtDDErQyQDFLEDL Y439-p
NMD3 (mouse) DtDDERQYQDFLEDL Y439
NMD3 (rat) DtDDERQYQDFLEDL Y439
K454-ub
EEDEAIRkNVNIyRD
0 1
NMD3 (human) EEDEAIRkNVNIyRD K454-ub
NMD3 (mouse) EEDEAIRKHVNIYRD K454
NMD3 (rat) EEDETIRKNVNIYRD K454
Y459-p
IRkNVNIyRDsAIPV
Upstream
0 1
Treatment
  • BI2536
  • MLN8054
NMD3 (human) IRkNVNIyRDsAIPV Y459-p
NMD3 (mouse) IRKHVNIYRDATIPV Y459
NMD3 (rat) IRKNVNIYRDSTVPV Y459
S462-p
NVNIyRDsAIPVEsD
Upstream
0 3
Treatment
  • BI2536
NMD3 (human) NVNIyRDsAIPVEsD S462-p
NMD3 (mouse) HVNIYRDATIPVEsD A462
NMD3 (rat) NVNIYRDSTVPVEsD S462
S468-p
DsAIPVEsDtDDEGA
Upstream
0 64
Treatment
  • dasatinib
  • lapatinib
NMD3 (human) DsAIPVEsDtDDEGA S468-p
NMD3 (mouse) DATIPVEsDtDDEGA S468-p
NMD3 (rat) DSTVPVEsDtDDEGA S468-p
T470-p
AIPVEsDtDDEGAPR
Upstream
0 76
Treatment
  • BI2536
  • lapatinib
NMD3 (human) AIPVEsDtDDEGAPR T470-p
NMD3 (mouse) TIPVEsDtDDEGAPR T470-p
NMD3 (rat) TVPVEsDtDDEGAPR T470-p
S479-p
DEGAPRIsLAEMLED
0 1
NMD3 (human) DEGAPRIsLAEMLED S479-p
NMD3 (mouse) DEGAPRISLAEMLED S479
NMD3 (rat) DEGAPRISLAEMLED S479
S490-p
MLEDLHIsQDATGEE
0 5
NMD3 (human) MLEDLHIsQDATGEE S490-p
NMD3 (mouse) MLEDLHISQDATGEE S490
NMD3 (rat) MLEDLRISQDATGEE S490